Literature DB >> 18663322

Outcomes of stage 3-5 chronic kidney disease before end-stage renal disease at a single center in Taiwan.

Yen-Ling Chiu1, Kuo-Liong Chien, Shuei-Liong Lin, Yung-Ming Chen, Tun-Jun Tsai, Kwan-Dun Wu.   

Abstract

BACKGROUND: Taiwan has the highest incidence of end-stage renal disease (ESRD) in the world, but little is known about the outcomes of patients with chronic kidney disease (CKD) before ESRD in Taiwan. This study investigated the rate of renal progression and predictors for ESRD and death in a prospective cohort of patients under usual nephrologic care at a single center.
METHODS: A total of 433 patients at CKD stage 3-5 short of dialysis were recruited from nephrology clinics. Patients were monitored for up to 36 months or until ESRD, death or loss to follow-up. Glomerular filtration rates (GFR) were calculated by the Modification of Diet in Renal Disease abbreviated formula.
RESULTS: At baseline, mean age was 65.6 years, 61.7% were male, 33.3% were diabetic and 29.1% had cardiovascular diseases (CVD). At the end of follow-up, 123 patients (28.4%) had advanced to ESRD and 41 (9.5%) had died. Mean annual declines in GFR were 2.24, 4.22, and 3.23 ml/min/1.73 m(2) for stages 3, 4, and 5, respectively. By Cox regression model, patients with CVD, lower BMI and higher systolic BP were more likely to develop ESRD. Older patients with CVD and lower systolic BP were more likely to die.
CONCLUSION: In this CKD cohort, patients were more likely to develop ESRD than cardiovascular death. The rate of GFR decline and predictors of ESRD were comparable to those reported in Western countries. Thus, the high incidence of ESRD in Taiwan may be attributed, at least in part, to lower cardiovascular mortality. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2008        PMID: 18663322     DOI: 10.1159/000145453

Source DB:  PubMed          Journal:  Nephron Clin Pract        ISSN: 1660-2110


  23 in total

1.  Cancer-specific mortality in chronic kidney disease: longitudinal follow-up of a large cohort.

Authors:  Pei-Hsuan Weng; Kuan-Yu Hung; Hsien-Liang Huang; Jen-Hau Chen; Pei-Kun Sung; Kuo-Chin Huang
Journal:  Clin J Am Soc Nephrol       Date:  2011-04-21       Impact factor: 8.237

2.  Applying the Temporal Abstraction Technique to the Prediction of Chronic Kidney Disease Progression.

Authors:  Li-Chen Cheng; Ya-Han Hu; Shr-Han Chiou
Journal:  J Med Syst       Date:  2017-04-11       Impact factor: 4.460

3.  Risk factors associated with disease progression and mortality in chronic kidney disease of uncertain etiology: a cohort study in Medawachchiya, Sri Lanka.

Authors:  Lalantha Senevirathna; Tilak Abeysekera; Shanika Nanayakkara; Rohana Chandrajith; Neelakanthi Ratnatunga; Kouji H Harada; Toshiaki Hitomi; Toshiyuki Komiya; Eri Muso; Akio Koizumi
Journal:  Environ Health Prev Med       Date:  2011-09-01       Impact factor: 3.674

Review 4.  Time to differentiate 'decreased kidney function' from 'kidney disease': towards improving the definition of chronic kidney disease.

Authors:  Malvinder S Parmar
Journal:  Int Urol Nephrol       Date:  2012-01-05       Impact factor: 2.370

Review 5.  Chronic kidney disease prediction is an inexact science: The concept of "progressors" and "nonprogressors".

Authors:  Macaulay Amechi Chukwukadibia Onuigbo; Nneoma Agbasi
Journal:  World J Nephrol       Date:  2014-08-06

6.  Clinical outcomes and predictors for ESRD and mortality in primary GN.

Authors:  Yu-Hsiang Chou; Yu-Chung Lien; Fu-Chang Hu; Wei-Chou Lin; Chih-Chin Kao; Chun-Fu Lai; Wen-Chih Chiang; Shuei-Liong Lin; Tun-Jun Tsai; Kwan-Dun Wu; Yung-Ming Chen
Journal:  Clin J Am Soc Nephrol       Date:  2012-07-12       Impact factor: 8.237

Review 7.  Diabetic Nephropathy and CKD-Analysis of Individual Patient Serum Creatinine Trajectories: A Forgotten Diagnostic Methodology for Diabetic CKD Prognostication and Prediction.

Authors:  Macaulay Amechi Chukwukadibia Onuigbo; Nneoma Agbasi
Journal:  J Clin Med       Date:  2015-06-26       Impact factor: 4.241

8.  Volume overload and adverse outcomes in chronic kidney disease: clinical observational and animal studies.

Authors:  Szu-Chun Hung; Yi-Shin Lai; Ko-Lin Kuo; Der-Cherng Tarng
Journal:  J Am Heart Assoc       Date:  2015-05-05       Impact factor: 5.501

9.  From Profusion to Confusion: The Saga of Managing Hypertension in Chronic Kidney Disease!

Authors:  Adrian Covic; David Goldsmith; Mihaela-Dora Donciu; Dimitrie Siriopol; Raluca Popa; Mehmet Kanbay; Gerard London
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-02-28       Impact factor: 3.738

10.  Baseline characteristics and prevalence of cardiovascular disease in newly visiting or referred chronic kidney disease patients to nephrology centers in Japan: a prospective cohort study.

Authors:  Soichiro Iimori; Yumi Noda; Tomokazu Okado; Shotaro Naito; Takayuki Toda; Yoshiko Chida; Michio Kuwahara; Ryoichi Ando; Yasuhide Nishio; Yoshitaka Maeda; Hiroyuki Tanaka; Teiichi Tamura; Shigeaki Kimoto; Eiichiro Kanda; Seiji Inoshita; Momono Yoshikawa; Rie Okutsu; Masato Tajima; Takashi Kusaura; Katsuki Kobayashi; Tatemitsu Rai; Shinichi Uchida; Sei Sasaki
Journal:  BMC Nephrol       Date:  2013-07-17       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.